- Home
- DOYU vs VRXA Comparison
DOYU vs VRXA Comparison
Compare DOYU & VRXA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DOYU | VRXA |
|---|---|---|
| Founded | 2014 | 2021 |
| Country | China | Germany |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 134.3M | 157.0M |
| IPO Year | 2019 | 2025 |
Fundamental Metrics
Financial Performance| Metric | DOYU | VRXA |
|---|---|---|
| Price | $3.55 | $1.03 |
| Analyst Decision | Hold | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $4.78 | N/A |
| AVG Volume (30 Days) | 28.8K | ★ 248.0K |
| Earning Date | 11-19-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.43 | $0.99 |
| 52 Week High | $7.23 | $4.50 |
Technical Indicators
Market Signals| Indicator | DOYU | VRXA |
|---|---|---|
| Relative Strength Index (RSI) | 26.71 | 38.41 |
| Support Level | N/A | $1.04 |
| Resistance Level | $4.90 | $1.41 |
| Average True Range (ATR) | 0.21 | 0.13 |
| MACD | -0.05 | 0.01 |
| Stochastic Oscillator | 4.00 | 17.81 |
Price Performance
Historical ComparisonAbout DOYU DouYu International Holdings Limited ADS
DouYu International Holdings Ltd is a game-centric live streaming platform in China and a pioneer in the eSports value chain. The company aims to build an integrated game-centric ecosystem of livestreaming, video, voice, graphic content, and other interactive and community features. The company operates the platform both on mobile apps and PC portals, through which users can enjoy immersive and interactive games and entertainment livestreaming, access a wide array of video and graphic content, and participate in community events and discussions.
About VRXA Veraxa Biotech AG Ordinary Shares
Veraxa Biotech Holding AG focus on antibody therapies in medicine. The Company is an oncology-focused biotechnology Company with a clinical program in acute myeloid leukemia and two proprietary platform technologies that enable the development of new generations of antibody drug conjugates (ADC's) and T cell engagers. The Company operates in one reportable segment, focused on the research and development of products for the aging population.